New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left"><img alt="942960.table.006" src="https://static.hindawi.com/articles/bmri/volume-2014/942960/figures/942960.table.006.jpg"/></td><td align="left"><sup>
                    18</sup>F-Fluordeoxyglucose (<sup>18</sup>F-FDG)<br/>(i) myocardial uptake (via glucose transporters) and retention second to metabolic activity<br/>(ii) surrogate for myocardial or vascular inflammation (macrophage burden)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

PET Myocardial Metabolism Radiotracers for Evaluation of Viability or Inflammation.

BioMed Research International

tab6

Table 6

Table 6: New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease 